|
Miscellaneous
topics
Ondansetron
plus metopimazine compared with ondansetron plus metopimazine
plus prednisolone as antiemetic prophylaxis in patients receiving
multiple cycles of moderately emetogenic chemotherapy.
Sigsgaard T, Herrstedt J, Handberg J, Kjaer M, Dombernowsky
P. J Clin Oncol. 2001;19:2091-7.
Exercise
reduces daily fatigue in women with breast cancer receiving
chemotherapy.
Schwartz AL, Mori M, Gao R, NAIL And LM, King ME. Med Sci
Sports Exerc. 2001;33:718-23.
A
Comparison of Breast Cancer Secondary Prevention Activities
and Satisfaction with Access and Communication Issues in Women
50 and over.
Roberts RA, Birch NJ. Prev Med. 2001;32:348-58.
The
use of between-methods triangulation in cancer nursing research:
a case study examining information sources for partners of
women with breast cancer.
Rees CE, Bath PA. Cancer Nurs. 2001;24:104-11.
A
family history of breast cancer: women's experiences from
a theoretical perspective.
Rees G, Fry A, Cull A. Soc Sci Med. 2001;52:1433-40.
Quality
of life in breast cancer patients - Not enough attention for
long-term survivors?
Holzner
B, Kemmler G, Kopp M, et al. Psychosomatics. 42(2):117-123,
2001 Mar-Apr.
A
body image scale for use with cancer patients.
Hopwood P, Fletcher I, Lee A, Ghazal SA. European Journal
of Cancer. 37(2):189-197, 2001 Jan.
Insomnia
in the context of cancer: A review of a neglected problem
[Review].
Savard J, Morin CM. Journal of Clinical Oncology. 19(3):895-908,
2001 Feb 1.
Patient
preference for cancer therapy: An overview of measurement
approaches.
Stiggelbout AM, de Haes JCJM. Journal of Clinical Oncology.
19(1):220-230, 2001 Jan 1.
Clinical
relevance of single item quality of life indicators in cancer
clinical trials.
Bernhard J, Sullivan M, Hurny C, Coates AS, Rudenstam CM.
Br J Cancer. 2001;84:1156-65.
Relation
between socioeconomic status and tumour stage in patients
with breast, colorectal, ovarian, and lung cancer: results
from four national, population based studies.
Brewster DH, Thomson CS, Hole DJ, Black RJ, Stroner PL, Gillis
CR. BMJ. 2001;322:830-1.
Caring
demands and delay in seeking care in African American women
newly diagnosed with breast cancer: an ethnographic, photographic
study.
Gates MF, Lackey NR, Brown G. Oncol Nurs Forum. 2001;28:529-37.
Factors
related to sexual function in postmenopausal women with a
history of breast cancer.
Greendale GA, Petersen L, Zibecchi L, Ganz PA. Menopause.
2001;8:111-9.
African
American women's experiences with the initial discovery, diagnosis,
and treatment of breast cancer.
Lackey NR, Gates MF, Brown G. Oncol Nurs Forum. 2001;28:519-27.
Quality
of life as an outcome measure in surgical oncology.
Langenhoff BS, Krabbe PF, Wobbes T, Ruers TJ. Br
J Surg. 2001;88:643-52.
Age
bias: a cause of underutilization of breast conservation treatment.
Madan AK, Aliabadi-Wahle S, Beech DJ. J Cancer Educ. 2001;16:29-32.
Alternative
therapies
Evaluation
of Estrogenic Activity of Plant Extracts for the Potential
Treatment of Menopausal Symptoms.
Liu
J, Burdette JE, Xu H, et al. J
Agric Food Chem. 2001;49:2472-2479.
Assessment
of outcomes at alternative medicine cancer clinics: A feasibility
study.
Richardson MA, Russell NC, Sanders T, Barrett R, Salveson
C. Journal of Alternative & Complementary Medicine. 7(1):19-32,
2001 Feb.
Complementary
and alternative medicine in early-stage breast cancer [Review].
Tagliaferri M, Cohen I, Tripathy D. Seminars in Oncology.
28(1):121-134, 2001 Feb.
Use
of Iscador, an extract of European mistletoe (Viscum album),
in cancer treatment: prospective nonrandomized and randomized
matched-pair studies nested within a cohort study.
Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R. Altern
Ther Health Med. 2001;7:57-66, 68-72, 74-6 passim.
Regular
consumption of green tea and the risk of breast cancer recurrence:
follow-up study from the Hospital-based Epidemiologic Research
Program at Aichi Cancer Center (HERPACC), Japan.
Inoue
M, Tajima K, Mizutani M, et al. Cancer Lett. 2001;167:175-82.
Randomized
trial of black cohosh for the treatment of hot flashes among
women with a history of breast cancer.
Jacobson
JS, Troxel AB, Evans J, et al. J Clin Oncol. 2001;19:2739-45.
Do
dietary phytoestrogens influence susceptibility to hormone-dependent
cancer by disrupting the metabolism of endogenous oestrogens?
Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ. Biochem
Soc Trans. 2001;29:209-16.
Estrogen
Receptor beta -Selective Transcriptional Activity and Recruitment
of Coregulators by Phytoestrogens.
An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman
DC. J Biol Chem. 2001;276:17808-14.
Financial
Long-term
breast cancer survivors: confidentiality, disclosure, effects
on work and insurance.
Stewart DE, Cheung AM, Duff S, et al. Psychooncology.
2001;10:259-63.
Measuring
the incremental cost of clinical cancer research.
Goldman DP, Schoenbaum ML, Potosky AL, et al. Journal of Clinical
Oncology. 19(1):105-110, 2001 Jan 1.
Reducing
the cost of diagnosis of breast carcinoma - Impact of ultrasound
and imaging-guided biopsies on a clinical breast practice.
Rubin
E, Mennemeyer ST, Desmond RA, et al. Cancer.
91(2):324-332, 2001 Jan 15.
Cost
comparison of mastectomy versus breast-conserving therapy
for early-stage breast cancer.
Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown
M. J Natl Cancer Inst. 2001;93:447-55.
Impact
of clinical trials on the cost of cancer care.
Chirikos TN, Ruckdeschel JC, Krischer JP. Med Care. 2001;39:373-83.
Cost
of genetic counseling and testing for brca1 and brca2 breast
cancer susceptibility mutations.
Lawrence WF, Peshkin BN, Liang W, Isaacs C, Lerman C, Mandelblatt
JS. Cancer Epidemiol Biomarkers Prev. 2001;10:475-81.
Psychosocial
issues
Risk,
severity and predictors of physical and psychological morbidity
after axillary lymph node dissection for breast cancer.
Ververs
JM, Roumen RM, Vingerhoets AJ, et al. Eur J Cancer. 2001;37:991-9.
Quality
of life and breast cancer: relationship to psychosocial variables.
Shapiro
SL, Lopez AM, Schwartz GE, et al. J Clin Psychol. 2001;57:501-19.
Coping
with breast cancer: Patient, spouse, and dyad models.
Ben-Zur
H, Gilbar O, Lev S. Psychosomatic Medicine. 63(1):32-39, 2001
Jan-Feb.
The
psychosocial impact of bilateral prophylactic mastectomy:
prospective study using questionnaires and semistructured
interviews.
Hatcher MB, Fallowfield L, A'Hern R. BMJ. 322(7278):76-79,
2001 Jan 13.
Decision
support for patients with early-stage breast cancer: effects
of an interactive breast cancer CDROM on treatment decision,
satisfaction, and quality of life.
Molenaar
S, Sprangers MA, Rutgers EJ, et al. J Clin Oncol. 2001;19:1676-87.
Coping
with grim news from genetic tests.
Horowitz M, Sundin E, Zanko A, Lauer R. Psychosomatics.
42(2):100-105,
2001 Mar-Apr.
Social
support as a buffer to the psychological impact of stressful
life events in women with breast cancer.
Kornblith
AB, Herndon JE, Zuckerman E, et al. Cancer.
91(2):443-454, 2001 Jan 15.
Predicting
mood disorders in breast cancer patients.
Morasso
G, Costantini M, Viterbori P, et al. European
Journal of Cancer. 37(2):216-223, 2001 Jan.
Predicting
anxiety and depression among cancer patients: a clinical model.
Nordin K, Berglund C, Glimelius B, Sjoden PO. European Journal
of Cancer. 37(3):376-384, 2001 Feb.
Psychophysiologic
assessment of posttraumatic stress disorder in breast cancer
patients.
Pitman RK, Lanes DM, Williston SK, et al. Psychosomatics.
42(2):133-140, 2001 Mar-Apr.
The
role of psychosocial factors in the development of breast
carcinoma: Part II - Life event stressors, social support,
defense style, and emotional control and their interactions.
Price MA, Tennant CC, Butow PN, et al. Cancer. 91(4):686-697,
2001 Feb 15.
Information
needs of patients with cancer: results from a large study
in UK cancer centres.
Jenkins V, Fallowfield L, Saul J. British Journal of Cancer.
84(1):48-51, 2001 Jan 5.
Structured
exercise improves physical functioning in women with stages
I and II breast cancer: Results of a randomized controlled
trial.
Segal R, Evans W, Johnson D, et al. Journal of Clinical Oncology.
19(3):657-665, 2001 Feb 1.
Fatigue
in disease-free cancer patients compared with fatigue in patients
with Chronic Fatigue Syndrome.
Servaes P, van der Werf S, Prins J, Verhagen S, Bleijenberg
G. Supportive Care in Cancer. 9(1):11-17, 2001 Jan.
How
successful are oncologists in identifying patient distress,
perceived social support, and need for psychosocial counselling?
Sollner
W, DeVries A, Steixner E, et al. British
Journal of Cancer. 84(2):179-185, 2001 Jan 19.
Depression
burden, self-help interventions, and side effect experience
in women receiving treatment for breast cancer.
Badger TA, Braden CJ, Mishel MH. Oncol Nurs Forum. 2001;28:567-74.
Patient-health
care provider communication during chemotherapy treatment:
the perspectives of women with breast cancer.
Bakker DA, Fitch MI, Gray R, Reed E, Bennett J. Patient Educ
Couns. 2001;43:61-71.
Psychosocial
care in family cancer clinics in The Netherlands: a brief
report.
Bleiker EM, Grosfeld FJ, Hahn DE, Honing C. Patient Educ Couns.
2001;43:205-9.
Spiritual
resources of Chinese immigrants with breast cancer in the
USA.
Chiu L. Int J Nurs Stud. 2001;38:175-84.
Supportive-expressive
group therapy and distress in patients with metastatic breast
cancer: a randomized clinical intervention trial.
Classen C, Butler LD, Koopman C, et al. Arch Gen Psychiatry.
2001;58:494-501.
Psychosocial
issues following a positive result of genetic testing for
BRCA1 and BRCA2 mutations: findings from a focus group and
a needs-assessment survey.
Di Prospero LS, Seminsky M, Honeyford J, et al. CMAJ. 2001;164:1005-9.
Tamoxifen
for the prevention of breast cancer: psychosocial impact on
women participating in two randomized controlled trials.
Fallowfield L, Fleissig A, Edwards R, et al. J Clin Oncol.
2001;19:1885-92.
Psychological
aspects of cancer screening in high-risk populations.
Kash KM, Dabney MK. Med Pediatr Oncol. 2001;36:519-24.
Fatigue
and hope: Relationships to psychosocial adjustment in korean
women with breast cancer.
Lee EH. Appl Nurs Res. 2001;14:87-93.
|
